Home > Journals > International Angiology > Past Issues > Articles online first > International Angiology 2021 Mar 19

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

 

International Angiology 2021 Mar 19

DOI: 10.23736/S0392-9590.21.04659-9

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Mid-term patency of iliac venous stenting for post-thrombotic syndrome: systematic review and meta-analysis

Adriana M. FERREIRA 1 , José OLIVEIRA-PINTO 1, 2, Luís DUARTE-GAMAS 1, 2, Andreia COELHO 1, Armando MANSILHA 1, 2

1 Faculty of Medicine, University of Porto, Porto, Portugal; 2 Department of Angiology and Vascular Surgery, Hospital São João, Porto, Portugal


PDF


INTRODUCTION: Post-thrombotic syndrome (PTS) is the most common chronic complication of deep vein thrombosis. Recent studies suggested that iliac stenting in chronic obstructive venous disease is safe and effective. However, systematic reviews focusing on mid-term efficacy of iliac stenting in post-thrombotic syndrome are lacking. This systematic review aimed to analyse mid-term stent patency rates and clinical outcomes of iliac stenting in post-thrombotic syndrome.
EVIDENCE ACQUISITION: Two databases were searched: Pubmed/Medline and SCOPUS. Articles published between January 2000 and July 2020 were selected and titles and abstracts were independently reviewed. Eighteen articles were included for the qualitative analysis. From this initial set of articles, fourteen articles were included for the quantitative analysis.
EVIDENCE SYNTHESIS: Overall, 1008 patients were included in this study. The pooled technical success rate was 96%. The pooled primary and secondary patency rates were 98.2% and 100% at 30 days, 78.1% and 94.5% at 12 months and 66.3% and 89.4% at 36 months, respectively. The rates of ulcer healing, pain and edema relief were 78.1%, 53.4% and 48.8%, respectively. The pooled rate of complications including intraoperative venous injury, back pain and stent fracture were 28%, 57.1%, and 5.9%, respectively.
CONCLUSIONS: Iliac venous stenting in PTS presents durable mid-term patency rates, as well as significant symptomatic improvement. Therefore, endovascular treatment should be considered in symptomatic patients with PTS.


KEY WORDS: Endovascular rocedures; Stent; Vein; Iliac vein

top of page